| 中文名称 | 倍氯米松 |
|---|---|
| 中文别名 | 倍氯美松;倍氯米松;甲醇中倍氯米松溶液标准物质;倍氯米松 标准品;倍氯米松杂质;9α-氯-11β,17α,21-三羟基-16β-甲基孕甾-1,4-二烯-3,20-二酮;9α-氯-16β-甲基孕甾-1,4-二烯-11β,17α,21-三醇-3,20-二酮;倍氯松 倍氯美松;甲醇中倍氯米松;丙酸倍氯米松 |
| 英文名称 | Beclometasone |
| 英文别名 | Pregna-1,4-diene-3,20-dione,9-chloro-11,17,21-trihydroxy-16-methyl-, (11b,16b)-;Beclomethasone;Beclomethasone Solution;(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;9-Chloro-11beta,17,21-trihydroxy-16beta-methyl-pregna-1,4-diene-3,20-dione;9-Chloro-16beta-methylprednisolone;9alpha-Chloro-16beta-methylprednisolone;Beclometasone;Becolvent;Beclometasona;BECLOMETHASONE [VANDF];Beclometasone-21-Propionate;pulvinal;NBMKJKDGKREAPL-DVTGEIKXSA-N;F85436;DTXSID5040750;Pregna-1,4-diene-3,20-dione, 9-chloro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-;R01AD01;Beclometasone-17-Propionate;CS-5872;NCGC00179392-03;MLS000028668;9-CHLORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE;EX-A4423;R03BA01;9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione;9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione (Beclometasone);(11beta,16beta)-9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;Beclometason (TN);SMP1_000039;(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-17-glycoloyl-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;Beclometasona [INN-Spanish];EINECS 224-585-9;NS00005005;UNII-KGZ1SLC28Z;MFCD00135614;CHEMBL1586;BECLOMETASONE [WHO-DD];9alpha-Chloro-16beta-methyl-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione;Beclometasonum (INN-Latin);HY-B1540;Beclometasone [INN:BAN];AKOS037645177;Beclometasona (INN-Spanish);BMJ 5800;Beclometasone (INN);SR-01000000273-4;9alpha-Chloro-11beta,17alpha,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione;D07495;BECLOMETHASONE [MI];BECLOMETASONE PROPIONATE;MLS001076089;NCGC00164402-01;C06842;Opera_ID_1081;HMS2233A18;SCHEMBL3183;Beclometasonum [INN-Latin];DTXCID3020750;BCBcMAP01_000159;A905224;Beclometasonum;AS-58067;GXR;Tox21_112116;(8~{S},9~{R},10~{S},11~{S},13~{S},14~{S},16~{S},17~{R})-9-chloranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;Pregna-1,4-diene-3,20-dione, 9-chloro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.beta.)-;SMR000058899;D07AC15;(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;CHEBI:3001;Beclometasone [INN];SR-01000000273;cid_20469;A07EA07;BDBM53488;Tox21_112116_1;KGZ1SLC28Z;(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;CAS-4419-39-0;Beclometason;4419-39-0;BIDD:GT0556;GTPL7059;AMY7469;Beclometasone Dipropionate;DA-71358 |
| CAS No. | 4419-39-0 |
| 分子式 | C22H29ClO5 |
| 分子量 | 408.92 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学